Thursday, December 25, 2008
GlaxoSmithKline working with Archemix
LONDON - GlaxoSmithKline PLC and Archemix Corp. said Tuesday they will work together to develop drugs for inflammatory diseases in a deal that could be worth as much as US$1.4 billion....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment